Antalpha Ventures, Web3Labs, and Goldford-HB Launch Computational Power Fund for AI and Web3 Projects
Antalpha Ventures, a global investment firm at the forefront of cutting-edge technology, has partnered with renowned Asian Web3 incubator Web3Labs and venture capital firm Goldford-HB to launch a new computational power fund. This fund aims to support early to mid-stage AI and Web3 projects worldwide by providing the necessary computational resources.
Fund Background
In today’s digital economy, artificial intelligence (AI) is a major driver of growth, with computational power emerging as the new “energy.” The demand for computational resources in AI training, inference, and other processes has surged, leading to rising costs. Recognizing these challenges, Antalpha Ventures, Web3Labs, and Goldford-HB have established this fund to assist emerging AI companies in overcoming these hurdles.
By leveraging our extensive computational power, along with our robust AI and Web3 networks and partnerships, we aim to incubate and accelerate high-quality, innovative AI and AI-related Web3 projects. Our computational power fund is designed to support early-stage projects, particularly those requiring significant computational resources, such as AI-generated content (AIGC) for text, images, and videos, as well as computational power platforms. This support will help projects reduce the high computational costs typically associated with the early stages of development.
Available Computational Power
The computational power fund from Antalpha Ventures, Web3Labs, and Goldford-HB will invest primarily through the provision of computational resources, valued at tens of millions of dollars. Our infrastructure is tailored for low-latency, high-processing-demand applications, including AI/ML training, inference, operations, and cloud gaming. The fund aims to democratize access to computational power, offering more options for engineers and businesses alike.
Project Requirements
We are seeking innovative projects in the following areas:
- Application-based projects with high computational power needs, including AI-generated text, images, and videos.
- Decentralized computational power platforms, focusing on AI training and inference.
- Other Web3+AI projects with related computational power requirements.
Priority will be given to teams with strong backgrounds and prior success in related fields.
For more information on how to apply, please email us at [email protected] or clicked in for more details ( https://mp.weixin.qq.com/s/Sq1MEki8WKjp8MjsYfPEiQ )
Related Posts
E-Tronic Provides Advanced EV Power Electronics Chips Supporting Efficient Battery Management (February 17, 2025)
Chinese startup E-Tronic specializes in power semiconductors and controller systems for the automotive industry. Their vehicle-grade 12V lithium battery management system (BMS) chip supports front-end analog acquisition, power management, intelligent watchdog, CAN/LIN communication, monitoring and diagnosis, high-side drive, and real-time clock. This enables li
” E-Tronic(Guangzhou) Technology” completes Series A financing led by Infinity Capital
E-Tronic(Guangzhou)Technology Co.,Ltd., a provider of power semiconductors and system solutions for new energy vehicles, has completed its Series A financing with a cumulative amount of over 100 million RMB. This round of financing was led by Infinity Capital, with additional investment from old shareholders Zhongnan Venture Capital and Guangzhou Development
Based on the SIPS model ChangYi proposes marketing strategies for big health brands
According to the “Gen Z Nutrition Consumption Trend Report,” consumers aged 18-35 account for 83.7% of the total health and wellness market, becoming the main force driving growth. Driven by the “Healthy China” initiative and shifting health awareness, the industry is rapidly developing amid fierce competition. Marketing focus has shifte
FDA Approves IND for LAE120, a Novel USP1 Inhibitor for Advanced Solid Tumors (March 4, 2025)
In March 2025, Laekna announced that the FDA approved the IND for LAE120, a novel USP1 inhibitor developed internally for advanced solid tumors. LAE120 shows potent monotherapy anti-tumor activity and synergy with PARP inhibitors, especially in homologous recombination deficiency (HRD) cancers. It demonstrated strong tumor inhibition in various xenograft models